Accelsiors

Accelsiors is a global contract research organization (CRO) specializing in clinical trial services and drug development consulting for emerging biotechs. The company operates across 40+ countries and 6 continents, offering integrated solutions powered by its proprietary Hexa-Helix™ framework—a six-strand approach combining Quality by Design (QbD), scientific integrity, operational efficiency, eClinical data systems, patient engagement, and AI/data security.

Core Clinical Services:

• Project management and trial monitoring (central and risk-based)
• Data management and eClinical systems (WideSCOPE Intelligence™)
• Drug safety management and pharmacovigilance
• Biostatistics and statistical programming
• Medical writing
• Quality assurance and record management
• Pharmacology, clinical pharmacology, modeling & simulation
• Real-world data and real-world evidence

Consulting & Regulatory:

• Regulatory consultancy and submissions guidance
• Medical and pharmacovigilance support
• Legal, GDPR, and representation services
• Drug development consultancy

Therapeutic Expertise: Endocrinology, autoimmune disorders, infectious diseases, respiratory, hepatology/gastrointestinal, nervous system, nephrology, women's health, oncology, biosimilars, generics, pediatric studies, cell and gene therapy, vaccines, microbiome, and orphan disorders.

Differentiation: Accelsiors emphasizes regulatory compliance across USA, EU, South Korea, and China; patient-centered study design (ProPATIENT Solutions™); and turnkey AI/data security (AcceShield™) addressing EU AI Act, NIS 2, and GDPR requirements. The company positions itself as a flexible functional service provider (FSP) tailored to emerging biotech needs.